Issue Date: September 7, 2009
Archimica And Chemic Partner On APIs
Archimica and Chemic Laboratories have formed a partnership for the development and commercialization of active pharmaceutical ingredients (APIs). The agreement will allow Canton, Mass.-based Chemic, which specializes in early-stage development of Drug Enforcement Agency-controlled substances and in APIs, to offer commercial-scale production in conjunction with Archimica. The German firm is hoping to expand its business in DEA-controlled substances, which it already produces in Springfield, Mo.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society